Vimarsana
Biggest News Aggregation in the World

Page 35 - Recommendation Statement News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Recommendation Statement. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Recommendation Statement Today - Breaking & Trending Today

Nikola Agrees to Acquire Romeo Power, To Bring Battery Pack Engineering and Production In-House - Vimarsana News

Nikola Agrees to Acquire Romeo Power, To Bring Battery Pack Engineering and Production In-House

/PRNewswire/ -- Nikola Corporation (NASDAQ: NKLA), and Romeo Power, Inc. (NYSE: RMO), today announced they have entered into a definitive agreement in which...

Aurora Capital Partners Commences Tender Offer For All Outstanding Shares of Sharps Compliance Corp. - Vimarsana News

Aurora Capital Partners Commences Tender Offer For All Outstanding Shares of Sharps Compliance Corp.

HOUSTON, July 25, 2022  /PRNewswire/ -- Aurora Capital Partners ('Aurora'), a leading middle-market private equity firm, today announced that its ...

Sharps Compliance To Be Acquired By an Affiliate of Aurora Capital Partners - Vimarsana News

Sharps Compliance To Be Acquired By an Affiliate of Aurora Capital Partners

HOUSTON, July 12, 2022 -- Sharps Compliance Corp. , a leading full-service national provider of comprehensive waste management solutions including medical, pharmaceutical and hazardous waste,... | July 12, 2022

FRO - Frontline Ltd. considers voluntary public takeover - Vimarsana News

FRO - Frontline Ltd. considers voluntary public takeover

        Notice in accordance with article 8, §1 of the Royal Decree of 27 April 2007 on Public Takeover Bids   Hamilton, Bermuda 11 July 2022 Frontline...

invoX Pharma Limited: invoX Pharma Commences Tender Offer for F-star Therapeutics, Inc. - Vimarsana News

invoX Pharma Limited: invoX Pharma Commences Tender Offer for F-star Therapeutics, Inc.

On July 7, 2022, invoX Pharma Limited ("invoX"), a wholly owned subsidiary of Sino Biopharmaceutical Limited ("Sino Biopharm") (HKEX 1177 HK) commenced a cash tender offer for all of the issued and